ArticleClinical and molecular hepatology2026

Bacteroides eggerthii: a new human gut probiotic against metabolic dysfunction-associated steatotic liver disease: Editorial on "Bacteroides eggerthii ameliorates metabolic dysfunction-associated steatotic liver disease through host-microbe signaling and highlights 2-hydroxyisocaproate as a potential effector".

Harry Cheuk-Hay Lau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.